Average Co-Inventor Count = 3.55
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (28 from 4,770 patents)
2. Merck Sharp + Dohme Corp. (22 from 2,405 patents)
3. Forma Therapeutics, Inc. (2 from 125 patents)
52 patents:
1. 11299484 - Inhibiting fatty acid synthase (FASN)
2. 10875848 - Inhibiting fatty acid synthase (FASN)
3. 10072025 - Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors
4. 10059705 - Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
5. 9957265 - N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors
6. 9725445 - Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors
7. 9637493 - Substituted pyrrolopyrimidines as HDM2 inhibitors
8. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors
9. 9096598 - Azaindoles as Janus kinase inhibitors
10. 8993756 - Pyrrolopyrimidines as janus kinase inhibitors
11. 8962608 - Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
12. 8937077 - Bicyclic diamines as janus kinase inhibitors
13. 8329722 - Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
14. 8222269 - Tyrosine kinase inhibitors
15. 8101603 - Tyrosine kinase inhibitors